Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label aftercare study of Velmanase Alfa in alpha-mannosidosis
2013-000321-31Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Jun 2013
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of velmanase alfa in alpha-mannosidosis, sponsored by Chiesi Farmaceutici S.p.A. Started Jun 2013; status: completed.
02
Drugs
velmanase alfa
03
Conditions
alpha-mannosidosis
Beyond the preview
Go deeper on 2013-000321-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000321-31.